It has been discovered that GIHCG acts as an oncogene by increasing the trimethylation and DNA methylation levels of the miR-200b/a/429 promoter H3K27, ultimately suppressing the expression of these miRNAs to promote the proliferation and metastasis of HCC cells [39]. This evidence concerns the gene GIHCG and hepatocellular carcinoma.